These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Genetics: Potassium channelopathy implicated in the pathogenesis of familial PAH. Roberts A Nat Rev Cardiol; 2013 Oct; 10(10):550. PubMed ID: 23939483 [No Abstract] [Full Text] [Related]
27. A novel channelopathy in pulmonary arterial hypertension. Morita H; Komuro I N Engl J Med; 2013 Nov; 369(22):2161-2. PubMed ID: 24283238 [No Abstract] [Full Text] [Related]
28. A novel channelopathy in pulmonary arterial hypertension. Olschewski A; Nagaraj C; Olschewski H N Engl J Med; 2013 Nov; 369(22):2161. PubMed ID: 24283237 [No Abstract] [Full Text] [Related]
29. A novel channelopathy in pulmonary arterial hypertension. Chung WK; Sampson KS; Kass RS N Engl J Med; 2013 Nov; 369(22):2162. PubMed ID: 24283236 [No Abstract] [Full Text] [Related]
30. Role of KCNK3 Dysfunction in Dasatinib-associated Pulmonary Arterial Hypertension and Endothelial Cell Dysfunction. Ribeuz HL; Willer AS; Chevalier B; Sancho M; Masson B; Eyries M; Jung V; Guerrera IC; Dutheil M; Jekmek KE; Laubry L; Carpentier G; Perez-Vizcaino F; Tu L; Guignabert C; Chaumais MC; Péchoux C; Humbert M; Hinzpeter A; Mercier O; Capuano V; Montani D; Antigny F Am J Respir Cell Mol Biol; 2024 Jul; 71(1):95-109. PubMed ID: 38546978 [TBL] [Abstract][Full Text] [Related]
31. Kcnk3 dysfunction exaggerates the development of pulmonary hypertension induced by left ventricular pressure overload. Lambert M; Mendes-Ferreira P; Ghigna MR; LeRibeuz H; Adão R; Boet A; Capuano V; Rucker-Martin C; Brás-Silva C; Quarck R; Domergue V; Vachiéry JL; Humbert M; Perros F; Montani D; Antigny F Cardiovasc Res; 2021 Nov; 117(12):2474-2488. PubMed ID: 33483721 [TBL] [Abstract][Full Text] [Related]
32. KCNK3 Variants Are Associated With Hyperaldosteronism and Hypertension. Manichaikul A; Rich SS; Allison MA; Guagliardo NA; Bayliss DA; Carey RM; Barrett PQ Hypertension; 2016 Aug; 68(2):356-64. PubMed ID: 27296998 [TBL] [Abstract][Full Text] [Related]
33. The role of genetics in pulmonary arterial hypertension. Ma L; Chung WK J Pathol; 2017 Jan; 241(2):273-280. PubMed ID: 27770446 [TBL] [Abstract][Full Text] [Related]
34. Implication of Potassium Channels in the Pathophysiology of Pulmonary Arterial Hypertension. Le Ribeuz H; Capuano V; Girerd B; Humbert M; Montani D; Antigny F Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32882918 [TBL] [Abstract][Full Text] [Related]
35. A Semiconductor Chip-Based Next Generation Sequencing Procedure for the Main Pulmonary Hypertension Genes. Gómez J; Reguero JR; Alvarez C; Junquera MR; Arango A; Morís C; Coto E Lung; 2015 Aug; 193(4):571-4. PubMed ID: 25917481 [TBL] [Abstract][Full Text] [Related]
36. Genetic variation in the two-pore domain potassium channel, TASK-1, may contribute to an atrial substrate for arrhythmogenesis. Liang B; Soka M; Christensen AH; Olesen MS; Larsen AP; Knop FK; Wang F; Nielsen JB; Andersen MN; Humphreys D; Mann SA; Huttner IG; Vandenberg JI; Svendsen JH; Haunsø S; Preiss T; Seebohm G; Olesen SP; Schmitt N; Fatkin D J Mol Cell Cardiol; 2014 Feb; 67():69-76. PubMed ID: 24374141 [TBL] [Abstract][Full Text] [Related]
37. New molecular targets of pulmonary vascular remodeling in pulmonary arterial hypertension: importance of endothelial communication. Guignabert C; Tu L; Girerd B; Ricard N; Huertas A; Montani D; Humbert M Chest; 2015 Feb; 147(2):529-537. PubMed ID: 25644906 [TBL] [Abstract][Full Text] [Related]